Horizon Inks License for Cell Line IP | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery has licensed human genetic modeling technology for use in cancer research from Italy's University of Torino Medical School, the company said today.

The firm will pay the university undisclosed fees for sub-licensing control of the related patent estate.

The patented technology, developed at Torino's Department of Oncological Sciences, is related to the use of panels of engineered isogenic human cell lines that model genetic mutations found in cancer patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.